Evidence map›Paper›PMID 37513683›Full record

ReviewNutrients2023

Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review.

Jose Enrique de la Rubia Ortí, Costanza Moneti, Pilar Serrano-Ballesteros, Gloria Castellano, Raquel Bayona-Babiloni, Ana Belén Carriquí-Suárez, María Motos-Muñoz, Belén Proaño, María Benlloch

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jose Enrique de la Rubia OrtíDepartment of Basic Medical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0001-6808-9505
Costanza MonetiDoctoral School, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.
Pilar Serrano-BallesterosResearch Department of Sesderma Laboratories, 46001 Valencia, Spain.
Gloria CastellanoCentro de Investigación Traslacional San Alberto Magno (CITSAM), Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0001-7284-880X
Raquel Bayona-BabiloniDepartment of Basic Medical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.
Ana Belén Carriquí-SuárezDepartment of Basic Medical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0001-9398-9839
María Motos-MuñozDepartment of Personality Psychology, Treatment and Methodology, Catholic University of Valencia San Vicente Mártir, 46100 Valencia, Spain.
Belén ProañoDepartment of Basic Medical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0002-3623-7363
María BenllochDepartment of Basic Medical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.ORCID 0000-0002-3342-6732
Universitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is characterized by varying degrees of difficulty in social interaction and communication. These deficits are often associated with gastrointestinal symptoms, indicating alterations in both intestinal microbiota composition and metabolic activities. The intestinal microbiota influences the function and development of the nervous system. In individuals with ASD, there is an increase in bacterial genera such as

Indexed as

Autism Spectrum DisorderGastrointestinal MicrobiomeBacteriaCatechinChildDysbiosisHumansCatechinepigallocatechin gallateAutism Spectrum Disorder (ASD)epigallocatechin-3-gallate (EGCG)inflammationmicrobiotaoxidative stress

Identifiers

PMID37513683
PMCPMC10383799
OpenAlexW4385257630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.